The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Update on Key Emerging Challenges in Cystic Fibrosis
Open accessAbstract
Cystic fibrosis (CF) is a multisystem disease causing severe chronic sinopulmonary disease and loss of pancreatic exocrine function, which affects approximately 70,000 individuals worldwide. New therapeutic developments over the last few decades have resulted in a significant increase in survival, with the median predicted survival now reaching the late thirties and more and more CF patients living well into adulthood. However, with this advent of new therapies and the associated increase in survival, new challenges in CF care have also emerged. Two of these challenges, i.e. chronic methicillin-resistant Staphylococcus aureus lung infection and patient adherence to very complicated and time-consuming therapeutic regimens, are reviewed in detail here. In addition, the ultimate challenge of treating the underlying cause of CF by correcting the dysfunction of the CF transmembrane conductance regulator chloride channel is reviewed, as agents to correct channel function will likely significantly alter CF clinical outcomes and treatment approaches in the next decade.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Webb, A. K. (2006) · Cited by 4,369
Identification of the Cystic Fibrosis Gene: Genetic Analysis
Kerem, B.-S., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M., & Tsui, L.-C. (1989) · Science · doi:10.1126/science.2570460 · Cited by 4,142
Interventions for enhancing medication adherence
Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., Agoritsas, T., Mistry, N., Iorio, A., Jack, S., et al. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub4 · Cited by 2,945
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
Ramsey, B. W., Davies, J., McElvaney, N. G., Tullis, E., Bell, S. C., Dřevínek, P., Griese, M., McKone, E. F., Wainwright, C. E., Konstan, M. W., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105185 · Cited by 2,195
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Gibson, R. L., Burns, J. L., & Ramsey, B. W. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200304-505so · Cited by 1,633
Lung Infections Associated with Cystic Fibrosis
Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.194-222.2002 · Cited by 1,628
Interventions for enhancing medication adherence
Haynes, R. B., Ackloo, E., Sahota, N., McDonald, H. P., & Yao, X. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub3 · Cited by 1,244
Proctor, R. A., von Eiff, C., Kahl, B. C., Becker, K., McNamara, P., Herrmann, M., & Peters, G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1384 · Cited by 1,175
PTC124 targets genetic disorders caused by nonsense mutations
Welch, E. M., Barton, E. R., Zhuo, J., Tomizawa, Y., Friesen, W. J., Trifillis, P., Paushkin, S., Patel, M., Trotta, C. R., Hwang, S., et al. (2007) · Nature · doi:10.1038/nature05756 · Cited by 1,137
Cystic Fibrosis Pulmonary Guidelines: Chronic Medications for Maintenance of Lung Health
Flume, P. A., O'Sullivan, B. P., Robinson, K. A., Goss, C. H., Mogayzel, P. J., Willey-Courand, D. B., Bujan, J., Finder, J., Lester, M., Quittell, L., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200705-664oc · Cited by 1,024
Ratjen, F., & Döring, G. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12567-6 · Cited by 885
Hess, L. M., Raebel, M. A., Conner, D. A., & Malone, D. C. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h018 · Cited by 756
Cystic Fibrosis Pulmonary Guidelines: Chronic Medications for Maintenance of Lung Health
Mogayzel, P. J., Naureckas, E. T., Robinson, K. A., Mueller, G., Hadjiliadis, D., Hoag, J. B., Lubsch, L., Hazle, L., Sabadosa, K., Marshall, B., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201207-1160oe · Cited by 615
Van Goor, F., Straley, K. S., Cao, D., González, J., Hadida, S., Hazlewood, A., Joubran, J., Knapp, T., Makings, L. R., Miller, M., et al. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00169.2005 · Cited by 512
Persistent and Relapsing Infections Associated with Small-Colony Variants of Staphylococcus aureus
Proctor, R. A., van Langevelde, P., Kristjansson, M., Maslow, J. N., & Arbeit, R. D. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.1.95 · Cited by 437
Ivacaftor potentiation of multiple CFTR channels with gating mutations
Yu, H., Burton, B., Huang, C.-J., Worley, J., Cao, D., Johnson, J. P., Urrutia, A., Joubran, J., Seepersaud, S., Sussky, K., et al. (2012) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2011.12.005 · Cited by 423
Kerem, E., Hirawat, S., Armoni, S., Yaakov, Y., Shoseyov, D., Cohen, M., Nissim-Rafinia, M., Blau, H., Rivlin, J., Aviram, M., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61168-x · Cited by 403
Kahl, B., Herrmann, M., Everding, A. S., Koch, H. G., Becker, K., Harms, E., Proctor, R. A., & Peters, G. (1998) · Journal of Infectious Diseases · doi:10.1086/515238 · Cited by 357
Evidence for airway surface dehydration as the initiating event in CF airway disease
Boucher, R. C. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01744.x · Cited by 356
Dasenbrook, E. C. (2010) · JAMA · doi:10.1001/jama.2010.791 · Cited by 353
Ivacaftor in subjects with cystic fibrosis who are homozygous for the F508del-CFTR mutation
Flume, P. A., Liou, T. G., Borowitz, D. S., Li, H., Yen, K., Ordoñez, C. L., & Geller, D. E. (2012) · Chest · doi:10.1378/chest.11-2672 · Cited by 338
Kahana, S., Drotar, D., & Frazier, T. (2008) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsm128 · Cited by 334
Persistent Methicillin-resistant Staphylococcus aureus and Rate of FEV 1 Decline in Cystic Fibrosis
Dasenbrook, E. C., Merlo, C. A., Diener-West, M., Lechtzin, N., & Boyle, M. P. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200802-327oc · Cited by 319
Self-citationvon Eiff, C., Heilmann, C., Proctor, R. A., Woltz, C., Peters, G., & Götz, F. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.15.4706-4712.1997 · Cited by 310
Cystic fibrosis: a disease of vulnerability to airway surface dehydration
Boucher, R. C. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.05.001 · Cited by 273
Du, M., Liu, X., Welch, E. M., Hirawat, S., Peltz, S. W., & Bedwell, D. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711795105 · Cited by 256
Longitudinal association between medication adherence and lung health in people with cystic fibrosis
Eakin, M. N., Bilderback, A., Boyle, M. P., Mogayzel, P. J., & Riekert, K. A. (2011) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2011.03.005 · Cited by 246
Self-citationSmall-Colony Variants of Pseudomonas aeruginosa in Cystic Fibrosis
Rohde, M. (1999) · Clinical Infectious Diseases · doi:10.1086/598644 · Cited by 238
Accurate Assessment of Adherence
Daniels, T., Goodacre, L., Sutton, C., Pollard, K., Conway, S., & Peckham, D. (2011) · Chest · doi:10.1378/chest.09-3074 · Cited by 210
Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis
Wilschanski, M., Miller, L. L., Shoseyov, D., Blau, H., Rivlin, J., Aviram, M., Cohen, M., Armoni, S., Yaakov, Y., Pugatch, T., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00120910 · Cited by 205
von Eiff, C., Becker, K., Metze, D., Lubritz, G., Hockmann, J., Schwarz, T., & Peters, G. (2001) · Clinical Infectious Diseases · doi:10.1086/320519 · Cited by 190
Smith, B. A., Modi, A. C., Quittner, A. L., & Wood, B. L. (2010) · Pediatric Pulmonology · doi:10.1002/ppul.21238 · Cited by 185
Vaudaux, P., Francois, P., Bisognano, C., Kelley, W. L., Lew, D. P., Schrenzel, J., Proctor, R. A., McNamara, P. J., Peters, G., & Von Eiff, C. (2002) · Infection and Immunity · doi:10.1128/iai.70.10.5428-5437.2002 · Cited by 183
Kahl, B. C., Duebbers, A., Lubritz, G., Haeberle, J., Koch, H. G., Ritzerfeld, B., Reilly, M., Harms, E., Proctor, R. A., Herrmann, M., et al. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.9.4424-4427.2003 · Cited by 175
Besier, S., Smaczny, C., von Mallinckrodt, C., Krahl, A., Ackermann, H., Brade, V., & Wichelhaus, T. A. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01510-06 · Cited by 164
Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis
Goss, C. H., Mayer-Hamblett, N., Aitken, M. L., Rubenfeld, G. D., & Ramsey, B. W. (2004) · Thorax · doi:10.1136/thx.2003.017707 · Cited by 159
Rosenstein, B. J., & Zeitlin, P. L. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09174-5 · Cited by 159
Bucks, R. S., Hawkins, K., Skinner, T. C., Horn, S., Seddon, P., & Horne, R. (2009) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsn135 · Cited by 151
Molecular targeting of CFTR as a therapeutic approach to cystic fibrosis
Amaral, M. D., & Kunzelmann, K. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.05.004 · Cited by 142
Phenotypic switching of antibiotic resistance circumvents permanent costs in Staphylococcus aureus
Massey, R. C., Buckling, A., & Peacock, S. J. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00507-3 · Cited by 141
Boyle, M. (2007) · JAMA · doi:10.1001/jama.298.15.1787 · Cited by 138
Self-citationGeorge, M., Rand-Giovannetti, D., Eakin, M. N., Borrelli, B., Zettler, M., & Riekert, K. A. (2010) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2010.08.016 · Cited by 118
Self-citationMolecular analysis of fusidic acid resistance in Staphylococcus aureus
Besier, S. M., Ludwig, A., Brade, V., & Wichelhaus, T. A. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03307.x · Cited by 116
Moisan, H., Brouillette, E., Jacob, C. L., Langlois-Bégin, P., Michaud, S., & Malouin, F. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.1.64-76.2006 · Cited by 116
Prospective evaluation of emerging bacteria in cystic fibrosis
Steinkamp, G., Wiedemann, B., Rietschel, E., Krahl, A., Gielen, J., Bärmeier, H., & Ratjen, F. A. (2005) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2004.10.002 · Cited by 114
Biological Cost of Rifampin Resistance from the Perspective of Staphylococcus aureus
Wichelhaus, T. A., Böddinghaus, B., Besier, S. M., Schäfer, V., Brade, V., & Ludwig, A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3381-3385.2002 · Cited by 111
Gentzsch, M., Dang, H., Dang, Y. L., García-Caballero, A., Suchindran, H., Boucher, R. C., & Stutts, M. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.155259 · Cited by 109
Bates, D. M., Eiff, C. V., McNamara, P. J., Peters, G., Yeaman, M. R., Bayer, A. S., & Proctor, R. A. (2003) · The Journal of Infectious Diseases · doi:10.1086/374642 · Cited by 106
Kahl, B. C., Belling, G., Becker, P., Chatterjee, I., Wardecki, K., Hilgert, K., Cheung, A. L., Peters, G., & Herrmann, M. (2005) · Infection and Immunity · doi:10.1128/iai.73.7.4119-4126.2005 · Cited by 102
Adherence with tobramycin inhaled solution and health care utilization
Briesacher, B. A., Quittner, A. L., Saiman, L., Sacco, P., Fouayzi, H., & Quittell, L. M. (2011) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-11-5 · Cited by 95
Sadowska, B., Bonar, A., Eiff, C., Proctor, R. A., Chmiela, M., Rudnicka, W., & Róźalska, B. (2002) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2002.tb00553.x · Cited by 92
Kahl, B. C., Belling, G., Reichelt, R., Herrmann, M., Proctor, R. A., & Peters, G. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.1.410-413.2003 · Cited by 92
Bregnballe, V., Schiøtz, Boisen, Pressler, T., & Thastum (2011) · Patient Preference and Adherence · doi:10.2147/ppa.s25308 · Cited by 90
Elizur, A., Orscheln, R. C., Ferkol, T. W., Atkinson, J. J., Dunne, W. M., Buller, R. S., Armstrong, J. R., Mardis, E. R., Storch, G. A., & Cannon, C. L. (2007) · CHEST Journal · doi:10.1378/chest.06-2756 · Cited by 88
Dziuban, E. J., Saab‐Abazeed, L., Chaudhry, S. R., Streetman, D. S., & Nasr, S. Z. (2010) · Pediatric Pulmonology · doi:10.1002/ppul.21195 · Cited by 88
Naon, H., Hack, S. L., Shelton, M. T., Gotthoffer, R. C., & Gozal, D. (1993) · CHEST Journal · doi:10.1378/chest.103.6.1819 · Cited by 88
Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis
Gilligan, P. H., Gage, P. A., Welch, D. F., Muszynski, M. J., & Wait, K. J. (1987) · Journal of Clinical Microbiology · doi:10.1128/jcm.25.7.1258-1261.1987 · Cited by 87
Sloane, P. A., & Rowe, S. M. (2010) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32833f1d00 · Cited by 86
von Eiff, C., Vaudaux, P. E., Kahl, B. C., Lew, D., Emler, S., Schmidt, A., Peters, G., & Proctor, R. A. (1999) · Clinical Infectious Diseases · doi:10.1086/520462 · Cited by 85
Sifri, C. D., Baresch-Bernal, A., Calderwood, S. B., & von Eiff, C. (2006) · Infection and Immunity · doi:10.1128/iai.74.2.1091-1096.2006 · Cited by 84
Glikman, D., Siegel, J. D., David, M. Z., Okoro, N., Boyle‐Vavra, S., Dowell, M. L., & Daum, R. S. (2008) · CHEST Journal · doi:10.1378/chest.07-2437 · Cited by 82
McNamara, P. S., McCormack, P., McDonald, A. J., Heaf, L., & Southern, K. W. (2009) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2009.04.006 · Cited by 72
Birth Prevalence and Survival in Cystic Fibrosis
Slieker, M. G., Uiterwaal, C. S. P. M., Sinaasappel, M., Heijerman, H. G. M., van der Laag, J., & van der Ent, C. K. (2005) · CHEST Journal · doi:10.1378/chest.128.4.2309 · Cited by 70
Häußler, S., Lehmann, C., Breselge, C., Rohde, M., Claßen, M., Tümmler, B., Vandamme, P. A. R., & Steinmetz, I. (2003) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-003-0901-y · Cited by 68
Molina, A., del Campo, R., Maiz, L., Morosini, M. I., Lamas, A., Baquero, F., & Cantón, R. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn302 · Cited by 67
Jonsson, I., von Eiff, C., Proctor, R. A., Peters, G., Rydèn, C., & Tarkowski, A. (2003) · Microbial Pathogenesis · doi:10.1016/s0882-4010(02)00208-5 · Cited by 66
Abele-Horn, M., Schupfner, B., Emmerling, P., Waldner, H., & Göring, H. (2000) · Infection · doi:10.1007/s150100050014 · Cited by 65
Self-management education for cystic fibrosis
Savage, E., Beirne, P. V., Chróinín, M. N., Duff, A. J. A., Fitzgerald, T., & Farrell, D. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007641.pub2 · Cited by 64
MacFarlane, M., Leavy, A., McCaughan, J., Fair, R., & Reid, A. J. M. (2006) · Journal of Hospital Infection · doi:10.1016/j.jhin.2006.10.011 · Cited by 61
Besier, S. M., Ludwig, A., Brade, V., & Wichelhaus, T. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1426-1431.2005 · Cited by 58
Spanu, T., Romano, L., D’Inzeo, T., Masucci, L., Albanese, A., Papacci, F., Marchese, E., Sanguinetti, M., & Fadda, G. (2005) · Clinical Infectious Diseases · doi:10.1086/432577 · Cited by 55
Ball, R., Southern, K. W., McCormack, P., Duff, A. J. A., Brownlee, K. G., & McNamara, P. S. (2013) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2012.12.012 · Cited by 53
Community-Acquired Methicillin-Resistant Staphylococcus aureus: The New Face of an Old Foe?
Udo, E. E. (2013) · Medical Principles and Practice · doi:10.1159/000354201 · Cited by 52
CLUNES, M., & Boucher, R. C. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.04.006 · Cited by 50
Geller, D. E., & Kesser, K. C. (2010) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2009.0793 · Cited by 49
Adherence to nebulised antibiotics in cystic fibrosis
Latchford, G. J., Duff, A. J. A., Quinn, J., Conway, S., & Conner, M. T. (2008) · Patient Education and Counseling · doi:10.1016/j.pec.2008.08.027 · Cited by 49
Adherence to dornase alfa treatment among commercially insured patients with cystic fibrosis
Nasr, S. Z., Chou, W., Villa, K. F., Chang, E., & Broder, M. S. (2013) · Journal of Medical Economics · doi:10.3111/13696998.2013.787427 · Cited by 44
Body satisfaction, nutritional adherence, and quality of life in youth with cystic fibrosis
Simon, S. L., Duncan, C. L., Horky, S. C., Nick, T. G., Castro, M. S. M., & Riekert, K. A. (2011) · Pediatric Pulmonology · doi:10.1002/ppul.21477 · Cited by 39
Self-citationRecurrent Infections by a Stable Dwarf-colony Variant of Staphylococcus aureus
Goudie, J. G., & Goudie, R. B. (1955) · Journal of Clinical Pathology · doi:10.1136/jcp.8.4.284 · Cited by 38
Economic impact of tobramycin in patients with cystic fibrosis in a managed care population
Wertz, D. A., Chang, C., Stephenson, J. J., Zhang, J., & Kuhn, R. J. (2011) · Journal of Medical Economics · doi:10.3111/13696998.2011.621004 · Cited by 13
Adherence to Pancreatic Enzyme Supplementation: In Adolescents with Cystic Fibrosis
Faulkner, C., Taper, L. J., & Scott, M. (2012) · Canadian Journal of Dietetic Practice and Research · doi:10.3148/73.4.2012.196 · Cited by 5
Research works printed but not linked: 5
- 10.1016/j.jcf.2009.11.009 · doi:10.1016/j.jcf.2009.11.009
- 10.1016/j.jhin.2003.12.003 · doi:10.1016/j.jhin.2003.12.003
- 10.1002/ppul.10231 · doi:10.1002/ppul.10231
- 10.1002/ppul.21315 · doi:10.1002/ppul.21315
- 10.1016/S0140-6736(12)60617-5 · doi:10.1016/s0140-6736(12)60617-5
Cited by
A haplotype map of the human genome
The International HapMap Consortium (2005) · Nature · doi:10.1038/nature04226 · Cited by 5,858
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
A Comparison of Bayesian Methods for Haplotype Reconstruction from Population Genotype Data
Stephens, M., & Donnelly, P. (2003) · The American Journal of Human Genetics · doi:10.1086/379378 · Cited by 3,513
Interventions for enhancing medication adherence
Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., Agoritsas, T., Mistry, N., Iorio, A., Jack, S., et al. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub4 · Cited by 2,945
Predicting the Functional Effect of Amino Acid Substitutions and Indels
Choi, Y., Sims, G. E., Murphy, S., Miller, J. R., & Chan, A. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046688 · Cited by 2,890
Metadata
- Authors
- Jennings, M. T., Riekert, K. A., & Boyle, M. P.
- Venue
- Medical Principles and Practice
- Publisher
- S. Karger AG
- Published
- 2014
- Volume
- 23
- Issue
- 5
- Pages
- 393-402
- ISSN
- 1011-7571 (ISSN-L)
- 1423-0151
- OpenAlex
- W2078078890
- Cited by
- 3,648
- References
- 81
- FWCI
- 259.52
- Type
- journal article
- Language
- en
- Open access
- diamond
- Licence
- creativecommons.org/licenses/by-nc/3.0/ (vor)
- creativecommons.org/licenses/by-nc/3.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.